Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 10 of 10 for “"Gynecological cancer"”.

  1. Impact of Pelvic Floor Dysfunction on Quality of Life in Cancer Survivors and Development of Pelvic Floor Muscle Rehabilitation Program

    … dysfunction and its impact on quality of life in gynecological cancer survivors and to assess the effects of pelvic floor muscle rehabilitation program on pelvic floor dysfunction and quality of life in gynecological cancer survivors by a prospective randomized controlled trial. Methods: …

    ajou Repository record for Impact of Pelvic Floor Dysfunction on Quality of Life in Cancer Survivors and Development of Pelvic Floor Muscle Rehabilitation Program (opens in a new tab)

  2. Utilizing data mining techniques and ensemble learning to predict development of surgical site infections in gynecologic cancer patients

    … common form of a hospital acquired infection. Gynecological cancer surgery patients are already at higher risk of developing an infection due to the suppression of their immune system. This research leverages popular data mining techniques to create a prediction model to identify high risk …

    binghamton Repository record for Utilizing data mining techniques and ensemble learning to predict development of surgical site infections in gynecologic cancer patients (opens in a new tab)

  3. Persistent Oxidative Damage Accounts for the Origin of Mutations Observed in Uterine Pathology

    … disorders of the same organ. Endometrial cancer, the most prevalently diagnosed gynecological cancer, is associated with mutated PTEN tumor suppressor gene. The type I endometrial cancer PTEN hotspot mutation involves a cytosine to guanine transversion. The mechanism for C to G …

    utmb Repository record for Persistent Oxidative Damage Accounts for the Origin of Mutations Observed in Uterine Pathology (opens in a new tab)

  4. Novel Micropatterned Substrate for Investigation of Ovarian Cancer Aggregate Formation and Response to Epigenetic Drug Therapy

    Ovarian Cancer (OvCa) is the deadliest gynecological cancer, with 90% of mortality being a direct result of metastasis. At this late stage, ovarian cancer is more challenging to treat, with only approximately 20% of women at an advanced-stage surviving beyond 12 years after treatment. Tumorigenesis …

    houston Repository record for Novel Micropatterned Substrate for Investigation of Ovarian Cancer Aggregate Formation and Response to Epigenetic Drug Therapy (opens in a new tab)

  5. Effects of TGF-β Inhibitor on Chemoresistance in Ovarian Cancer Models

    … ovarian carcinoma (HGSC) is the most fatal gynecological cancer, due to the aggressive, heterogeneous nature of the tumours. Despite an initially favourable treatment response, patients with HGSC often develop resistance to the first-line platinum-based chemotherapies. In addition, the few …

    queens Repository record for Effects of TGF-β Inhibitor on Chemoresistance in Ovarian Cancer Models (opens in a new tab)

  6. Relationship of Illness Perception and Fear of Cancer Recurrence to Psychological Distress among Gynecologic Cancer Survivors

    Gynecologic cancer survivors account for approximately 9% of all cancer survivors, and about 40% of the gynecologic cancer survivors have been reported to experience some form of psychological distress. Further, fear of cancer recurrence is prevalent among gynecologic cancer survivors, and illness …

    utmb Repository record for Relationship of Illness Perception and Fear of Cancer Recurrence to Psychological Distress among Gynecologic Cancer Survivors (opens in a new tab)

  7. Proteomics characterization of HPV-independent Vulvar Cancer Tumour Progression and Metastasis by Mass Spectrometry

    Vulvar cancer is the fourth most common gynecological cancer around the world, constituting 5% of all gynecological cancers and 0.6% of total cancer cases in 2016. As a relatively rare cancer type, the average vulvar cancer incidence rate is three in 100 000 women each year. But, Australian …

    adelaide Repository record for Proteomics characterization of HPV-independent Vulvar Cancer Tumour Progression and Metastasis by Mass Spectrometry (opens in a new tab)